Stents Efficacious Alternative To Bypass In Multivessel Disease - ARTS Trial
This article was originally published in The Gray Sheet
Executive Summary
Coronary stents can save an estimated $4,500 in per-procedure, in-hospital costs over bypass surgery and are an efficacious alternative for patients with multivessel coronary disease, according to one-year follow-up results of the Arterial Revascularization Therapy Study (ARTS).
You may also be interested in...
Drug-Eluting Stent Payment Should Reflect Patient Complexity – Task Force
CMS should create differential drug-eluting stent DRG payment rates based on patient complexity to ensure adequate hospital reimbursement, a Society for Cardiovascular Angiography & Interventions task force report advises
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”